Company / Current Assets per Share
Anixa Biosciences Inc Current Assets per Share History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.69
FY2024
5-year range
$0.32 / $1.00
FY2020-FY2024
Trend
-16.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 10 years, ranging from $0.03 in FY2014 to $1.00 in FY2022.
Based on SEC 10-K filings.
0.69 in FY2024 with a 10-year CAGR of +36.7%.
Declined from $1.00 to $0.69 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +16.3%
- 10-Year CAGR
- +36.7%
Key checks
Key Insights
- In FY2024, current assets per share decreased 16.4% year-over-year.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.69 | -16.4% |
| FY2023 | $0.82 | -18.4% |
| FY2022 | $1.00 | +118.1% |
| FY2020 | $0.46 | +43.0% |
| FY2019 | $0.32 | -3.4% |
| FY2018 | $0.33 | -58.4% |
| FY2017 | $0.80 | +105.6% |
| FY2016 | $0.39 | -50.3% |
| FY2015 | $0.78 | +2497.5% |
| FY2014 | $0.03 | +477.1% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026